After-hours movers: AMC Entertainment, StoneCo, Fulcrum Therapeutics, and more
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Morgan Stanley Reiterates Equalweight Rating on StoneCo Ltd. (STNE)
May 14, 2024 12:08 PM EDTMorgan Stanley analyst Jorge Kuri reiterated an Equalweight rating and $16.50 price target on StoneCo Ltd. (NASDAQ: STNE)
The analyst comments "While we remain constructive on many of the primary drivers for merchant acquirers accelerating TPV growth in 2024, lower funding costs as rates... More
Citi Reiterates Buy Rating on StoneCo Ltd. (STNE)
May 14, 2024 9:56 AM EDTCiti analyst Gabriel Gusan reiterated a Buy rating and $20.00 price target on StoneCo Ltd. (NASDAQ: STNE)
The analyst comments "We look at Stone's FIDC portfolio evolution in CVM as a proxy for credit operations. The Credit portfolio reached R$592mn in... More
BofA Securities Reiterates Underperform Rating on Fulcrum Therapeutics (FULC)
May 14, 2024 8:47 AM EDTBofA Securities analyst Tazeen Ahmad reiterated an Underperform rating and $5.00 price target on Fulcrum Therapeutics (NASDAQ: FULC).
The analyst comments "FULC announced the company has entered an exclusive license agreement with Sanofi (ticker: SNY; covered by Graham Perry) for the ex-US development of losmapimod in... More
AMC Entertainment (AMC) PT Raised to $3.20 at Citi
May 14, 2024 6:37 AM EDTCiti analyst Jason Bazinet raised the price target on AMC Entertainment (NYSE: AMC) to $3.20 (from $3.10) while maintaining a Sell rating.
The analyst comments "Maintaining Our View Following our update, our target price goes from $3.10 to $3.20. To arrive at our target... More
